Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.5.1.2 (
DNA ligase
)
2,749
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have investigated whether J kappa recombination signal sequence (RS) binding protein (
RBP-J kappa
) has any partial catalytic activities involved in the VDJ recombination reaction, such as cleavage, ligation, and bending of DNA. Murine
RBP-J kappa
protein purified by J kappa-RS affinity chromatography did not show DNA cleavage activities but contained a strong
DNA ligase
activity. To obtain a large amount of purified
RBP-J kappa
protein, recombinant
RBP-J kappa
was synthesized in Escherichia coli as a fusion protein and also in silkworm cells. Although recombinant
RBP-J kappa
produced in silkworm cells could bind J kappa-RS, it failed to show either ligase or DNA bending activity. Since the DNA affinity-purified
RBP-J kappa
has the ligase activity, the
RBP-J kappa
protein may form a complex with a ligase in vivo. We have raised monoclonal antibodies against the
RBP-J kappa
fusion protein which was synthesized in E. coli and unable to bind J kappa-RS. Using the anti-
RBP-J kappa
monoclonal antibody we have shown that the
RBP-J kappa
protein is expressed ubiquitously in mammalian tissues. The ubiquitous expression of the
RBP-J kappa
protein is consistent with the hypothesis that the
RBP-J kappa
protein may have dual function [Furukawa et al. (1991) J. Biol. Chem. 266, 23334-23340].
...
PMID:Biochemical and immunological characterization of the DNA binding protein (RBP-J kappa) to mouse J kappa recombination signal sequence. 142 18